Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
27184 | 235 | 29.2 | 61% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
111 | 3 | THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY | 71244 |
1214 | 2 | FACTOR XIII//TRANSGLUTAMINASE//TRANSGLUTAMINASE 2 | 9158 |
27184 | 1 | ALPHA2 ANTIPLASMIN//CLIN PATHOL BIOCHEM//NC100692 | 235 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ALPHA2 ANTIPLASMIN | authKW | 1002504 | 12% | 27% | 29 |
2 | CLIN PATHOL BIOCHEM | address | 731968 | 6% | 43% | 13 |
3 | NC100692 | authKW | 292358 | 1% | 75% | 3 |
4 | ALPHA2 ANTIPLASMIN DEFICIENCY | authKW | 259875 | 1% | 100% | 2 |
5 | ALPHA2 PLASMIN INHIBITOR | authKW | 244872 | 3% | 27% | 7 |
6 | TC 99M NC100668 | authKW | 173249 | 1% | 67% | 2 |
7 | 5 BIOTINAMIDO PENTYLAMINE | authKW | 129938 | 0% | 100% | 1 |
8 | ALPHA 2 ANTIPLASMIN AP | authKW | 129938 | 0% | 100% | 1 |
9 | ALPHA2 PLASMIN INHIBITOR ALPHA2 PI | authKW | 129938 | 0% | 100% | 1 |
10 | ANTIPLASM | authKW | 129938 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 5372 | 46% | 0% | 108 |
2 | Peripheral Vascular Diseases | 1741 | 26% | 0% | 60 |
3 | Biochemistry & Molecular Biology | 178 | 26% | 0% | 61 |
4 | Medicine, Research & Experimental | 55 | 7% | 0% | 16 |
5 | Biophysics | 23 | 5% | 0% | 11 |
6 | Biochemical Research Methods | 17 | 4% | 0% | 9 |
7 | Rheumatology | 7 | 1% | 0% | 3 |
8 | Chemistry, Medicinal | 5 | 2% | 0% | 5 |
9 | Pharmacology & Pharmacy | 3 | 5% | 0% | 12 |
10 | Biotechnology & Applied Microbiology | 2 | 3% | 0% | 7 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLIN PATHOL BIOCHEM | 731968 | 6% | 43% | 13 |
2 | HEMOSTASIS RHEOL THROMBOSIS | 129938 | 0% | 100% | 1 |
3 | SECT HAEMOSTASIS THROMBOSIS | 129938 | 0% | 100% | 1 |
4 | WILLIAM K WARREN MED | 124932 | 2% | 19% | 5 |
5 | CONNECT TISSUE VASC | 64968 | 0% | 50% | 1 |
6 | ORTHOPAED SURGETY | 64968 | 0% | 50% | 1 |
7 | TECHNOL SEPARAT | 64968 | 0% | 50% | 1 |
8 | TED R MONTOYA HEMOPHILIA PROGRAM | 43311 | 0% | 33% | 1 |
9 | CLIN BIOCHEM KB 3011 | 25986 | 0% | 20% | 1 |
10 | GROVE | 20157 | 1% | 5% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | FIBRINOLYSIS | 16275 | 4% | 1% | 9 |
2 | THROMBOSIS RESEARCH | 9961 | 12% | 0% | 28 |
3 | JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2681 | 4% | 0% | 9 |
4 | THROMBOSIS AND HAEMOSTASIS | 2191 | 6% | 0% | 13 |
5 | FIBRINOLYSIS & PROTEOLYSIS | 2109 | 1% | 1% | 2 |
6 | BLOOD COAGULATION & FIBRINOLYSIS | 1931 | 3% | 0% | 7 |
7 | RESEARCH IN CLINIC AND LABORATORY | 1664 | 0% | 1% | 1 |
8 | BLOOD | 1208 | 8% | 0% | 18 |
9 | RICERCA IN CLINICA E IN LABORATORIO | 1040 | 1% | 0% | 2 |
10 | SEMINARS IN THROMBOSIS AND HEMOSTASIS | 781 | 2% | 0% | 4 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ALPHA2 ANTIPLASMIN | 1002504 | 12% | 27% | 29 | Search ALPHA2+ANTIPLASMIN | Search ALPHA2+ANTIPLASMIN |
2 | NC100692 | 292358 | 1% | 75% | 3 | Search NC100692 | Search NC100692 |
3 | ALPHA2 ANTIPLASMIN DEFICIENCY | 259875 | 1% | 100% | 2 | Search ALPHA2+ANTIPLASMIN+DEFICIENCY | Search ALPHA2+ANTIPLASMIN+DEFICIENCY |
4 | ALPHA2 PLASMIN INHIBITOR | 244872 | 3% | 27% | 7 | Search ALPHA2+PLASMIN+INHIBITOR | Search ALPHA2+PLASMIN+INHIBITOR |
5 | TC 99M NC100668 | 173249 | 1% | 67% | 2 | Search TC+99M+NC100668 | Search TC+99M+NC100668 |
6 | 5 BIOTINAMIDO PENTYLAMINE | 129938 | 0% | 100% | 1 | Search 5+BIOTINAMIDO+PENTYLAMINE | Search 5+BIOTINAMIDO+PENTYLAMINE |
7 | ALPHA 2 ANTIPLASMIN AP | 129938 | 0% | 100% | 1 | Search ALPHA+2+ANTIPLASMIN+AP | Search ALPHA+2+ANTIPLASMIN+AP |
8 | ALPHA2 PLASMIN INHIBITOR ALPHA2 PI | 129938 | 0% | 100% | 1 | Search ALPHA2+PLASMIN+INHIBITOR+ALPHA2+PI | Search ALPHA2+PLASMIN+INHIBITOR+ALPHA2+PI |
9 | ANTIPLASM | 129938 | 0% | 100% | 1 | Search ANTIPLASM | Search ANTIPLASM |
10 | CONGENITAL BLEEDING | 129938 | 0% | 100% | 1 | Search CONGENITAL+BLEEDING | Search CONGENITAL+BLEEDING |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | AOKI, N , (2005) THE PAST, PRESENT AND FUTURE OF PLASMIN INHIBITOR.THROMBOSIS RESEARCH. VOL. 116. ISSUE 6. P. 455-464 | 51 | 78% | 12 |
2 | FAVIER, R , AOKI, N , DE MOERLOOSE, P , (2001) CONGENITAL ALPHA(2)-PLASMIN INHIBITOR DEFICIENCIES: A REVIEW.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 114. ISSUE 1. P. 4-10 | 44 | 83% | 37 |
3 | ABDUL, S , LEEBEEK, FWG , RIJKEN, DC , DE WILLIGE, SU , (2016) NATURAL HETEROGENEITY OF ALPHA 2-ANTIPLASMIN: FUNCTIONAL AND CLINICAL CONSEQUENCES.BLOOD. VOL. 127. ISSUE 5. P. 538 -545 | 45 | 54% | 1 |
4 | CARPENTER, SL , MATHEW, P , (2008) ALPHA(2)-ANTIPLASMIN AND ITS DEFICIENCY: FIBRINOLYSIS OUT OF BALANCE.HAEMOPHILIA. VOL. 14. ISSUE 6. P. 1250 -1254 | 27 | 84% | 36 |
5 | YOSHINAGA, H , NAKAHARA, M , KOYAMA, T , SHIBAMIYA, A , NAKAZAWA, F , MILES, LA , HIROSAWA, S , AOKI, N , (2002) A SINGLE THYMINE NUCLEOTIDE DELETION RESPONSIBLE FOR CONGENITAL DEFICIENCY OF PLASMIN INHIBITOR.THROMBOSIS AND HAEMOSTASIS. VOL. 88. ISSUE 1. P. 144 -148 | 26 | 87% | 2 |
6 | COUGHLIN, PB , (2005) ANTIPLASMIN - THE FORGOTTEN SERPIN?.FEBS JOURNAL. VOL. 272. ISSUE 19. P. 4852 -4857 | 20 | 69% | 31 |
7 | LIJNEN, HR , (2001) GENE TARGETING IN HEMOSTASIS. ALPHA(2)-ANTIPLASMIN.FRONTIERS IN BIOSCIENCE. VOL. 6. ISSUE . P. D239 -D247 | 21 | 75% | 13 |
8 | AOKI, N , SUMI, Y , MIURA, O , HIROSAWA, S , (1993) HUMAN ALPHA(2)-PLASMIN INHIBITOR.PROTEOLYTIC ENZYMES IN COAGULATION, FIBRINOLYSIS, AND COMPLEMENT ACTIVATION, PART B. VOL. 223. ISSUE . P. 185-197 | 20 | 80% | 5 |
9 | YOSHINAGA, H , HIROSAWA, S , CHUNG, DH , MIYASAKA, N , AOKI, N , FAVIER, R , (2000) A NOVEL POINT MUTATION OF THE SPLICING DONOR SITE IN THE INTRON 2 OF THE PLASMIN INHIBITOR GENE.THROMBOSIS AND HAEMOSTASIS. VOL. 84. ISSUE 2. P. 307-+ | 18 | 64% | 3 |
10 | AOKI, N , (2005) DISCOVERY OF ALPHA(2)-PLASMIN INHIBITOR AND ITS CONGENITAL DEFICIENCY.JOURNAL OF THROMBOSIS AND HAEMOSTASIS. VOL. 3. ISSUE 4. P. 623-631 | 14 | 67% | 5 |
Classes with closest relation at Level 1 |